Table 3.
Adverse event | Simvastatin group | Control group | P |
---|---|---|---|
Elevated aspartate aminotransferase | 1 (2%) | 2 (4%) | 0.558 |
Elevated alanine aminotransferase | 1 (2%) | 5 (10%) | 0.092 |
Elevated creatine phosphokinase | 1 (2%) | 2 (4%) | 0.558 |
Myalgia | 2 (4%) | 3 (6%) | 0.646 |
Muscle weakness | 1 (2%) | 2 (4%) | 0.558 |
Abdominal pain | 4 (8%) | 6 (12%) | 0.505 |
Nausea | 6 (12%) | 4 (8%) | 0.505 |
Constipation | 0 (0%) | 1 (2%) | 0.315 |
Diarrhea | 0 (0%) | 1 (2%) | 0.315 |
Flatulence | 1 (2%) | 2 (4%) | 0.558 |
Asthenia | 2 (4%) | 4 (8%) | 0.400 |
Dizziness | 1 (2%) | 3 (6%) | 0.307 |
Headache | 2 (4%) | 4 (8%) | 0.400 |
Allergy | 0 (0%) | 1 (2%) | 0.315 |